In the Nov/Dec issue of European Pharmaceutical Manufacturer, Pratima Cherukuri, Chief Scientific Officer at Genezen answers vital questions surrounding bioprocessing at commercial scale and provides insight into the key challenges involved.
Read the full article here:
